Idinvest Partners — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.
BiotechHealthtech
Daniel Olive(Founder)
Co-investorsAgent CapitalAndera PartnersKurma PartnersPfizer Venture InvestmentsPureos BioventuresAlexandria+4 more
LumApps builds an AI Employee Hub, a SaaS platform that combines internal communications, productivity, and learning for enterprise workforces including desk and frontline employees.
Enterprise SoftwareFuture of WorkHR TechSaaSLyon, FR
Élie Mélois(Founder)inSébastien Ricard(Chairman of the Board & CEO)inVincent Ortiou(Chief Financial Officer)inStu Story(Chief Sales Officer)inEleonore Depardon(Chief Strategy & Transformation Officer)Alice Desbouvrie(Chief People Officer)in
Co-investorsBridgepointGoldman SachsEmblemIris CapitalBpifrance
Spacefill provides an Order Management System (OMS) that unifies inventory across warehouses, stores, and 3PLs, and automates order routing, prioritization, returns, and ship-from-store orchestration.
AI & Machine LearningLogistics & Supply ChainRetail TechSaaS
Maxime Huzar(Founder)in
Co-investorsKima VenturesLa FamigliaMaersk GrowthNGP CapitalEurazeo
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



















